Southwest Oncology Group

Also found in: Acronyms, Wikipedia.

Southwest Oncology Group



A clinical cooperative composed of cancer institutions in the southwestern U.S. that researches the value of innovation in treating and preventing cancer.
Mentioned in ?
References in periodicals archive ?
Three cycles of CHOP (3) plus radiotherapy (RT) is superior to eight cycles of CHOP alone for localized intermediate and high grade non-Hodgkin's lymphoma: a Southwest Oncology Group Study.
The Southwest Oncology Group is one of the largest cancer clinical trials cooperative research groups in the United States.
HLA phenotype was determined for 80 percent of the 689 stage II melanoma patients in the Southwest Oncology Group study.
Significant long-term patient benefit with BCG maintenance therapy: A southwest oncology group study.
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
8] The Southwest Oncology Group (SWOG) 8794/ National Cancer Institute of Canada (NCIC) PR-2 study involving 431 pT3 patients randomized to either early adjuvant radiotherapy or delayed treatment at relapse reported "well tolerated" short-term toxicity.
TAX-327 and Southwest Oncology Group (SWOG) Intergroup Protocol 99-16 studies.
The strategy behind maintenance chemotherapy--instituting second-line chemotherapy immediately following a clinical response but before evidence of recurrence--has gained popularity with many oncologists, after last year's release of results from GOG 178, a large study by the Southwest Oncology Group and the Gynecologic Oncology Group (J.
Conversely patients with a high recurrence score on Oncotype DX showed marked clinical benefit from subsequent adjuvant chemotherapy in this new retrospective analysis of prospectively collected data from the phase III Southwest Oncology Group (SWOG)-8814 study.
He also conducts research in bladder cancer and is the head of the Advanced Bladder Subcommittee in the Southwest Oncology Group Genitourinary Committee.
Swanson and his associates in the Southwest Oncology Group (SWOG) Genitourinary Committee assessed 425 men with pathology-proven pT3 prostate cancer.
From 1996 to 1999, trial S9623 led by the Southwest Oncology Group enrolled 520 patients.

Full browser ?